Search research articles
Contact Us
Filters
Showing results (331-340 of 354) with videos related to
Page
of 36
Sort By:
The Journal of Experimental Medicine
|
April 21, 2021
IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization
Caroline Lanz, Michael Schotsaert, Carsten Magnus, et al.
Bone Marrow Transplantation
|
August 5, 2000
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells
G Hale, P Jacobs, L Wood, et al.
Journal of Virology
|
March 9, 2012
Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction
Jyothi M Noronha, Mengya Liu, R Burke Squires, et al.
Plos Pathogens
|
June 17, 2021
Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection
Liliana Echavarría-Consuegra, Georgia M Cook, Idoia Busnadiego, et al.
Nature Nanotechnology
|
June 4, 2021
An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles
Archana Palika, Antonius Armanious, Akram Rahimi, et al.
The Journal of Experimental Medicine
|
March 20, 2025
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design
Kevin Groen, Roger Kuratli, Jannik Enkelmann, et al.
Open Forum Infectious Diseases
|
January 5, 2024
Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome
Martin Achleitner, Nina K Mair, Juliane Dänhardt, et al.
The Journal of Trauma and Acute Care Surgery
|
November 30, 2012
Military medical revolution: military trauma system
Lorne H Blackbourne, David G Baer, Brian J Eastridge, et al.
The Journal of Experimental Medicine
|
July 17, 2024
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
Sonja Fernbach, Nina K Mair, Irene A Abela, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor
G Mullen, J Napier, M Balestra, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 354) with videos related to
Sort By:
Page
of 36
The Journal of Experimental Medicine
|
April 21, 2021
IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization
Caroline Lanz, Michael Schotsaert, Carsten Magnus, et al.
Bone Marrow Transplantation
|
August 5, 2000
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells
G Hale, P Jacobs, L Wood, et al.
Journal of Virology
|
March 9, 2012
Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction
Jyothi M Noronha, Mengya Liu, R Burke Squires, et al.
Plos Pathogens
|
June 17, 2021
Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection
Liliana Echavarría-Consuegra, Georgia M Cook, Idoia Busnadiego, et al.
Nature Nanotechnology
|
June 4, 2021
An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles
Archana Palika, Antonius Armanious, Akram Rahimi, et al.
The Journal of Experimental Medicine
|
March 20, 2025
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design
Kevin Groen, Roger Kuratli, Jannik Enkelmann, et al.
Open Forum Infectious Diseases
|
January 5, 2024
Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome
Martin Achleitner, Nina K Mair, Juliane Dänhardt, et al.
The Journal of Trauma and Acute Care Surgery
|
November 30, 2012
Military medical revolution: military trauma system
Lorne H Blackbourne, David G Baer, Brian J Eastridge, et al.
The Journal of Experimental Medicine
|
July 17, 2024
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
Sonja Fernbach, Nina K Mair, Irene A Abela, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor
G Mullen, J Napier, M Balestra, et al.
Page
of 36